CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Cash Flows [Abstract]
Total cash, cash equivalents, and restricted cash	$ 25,110	$ 25,340	$ 20,737
Cash flows from operating activities
Net income/(loss)	4,329	(2,152)	17,910
Depreciation and tooling amortization	7,690	7,642	7,318
Other amortization	(1,167)	(1,149)	(1,358)
(Gains)/Losses on Extinguishment of Debt	0	121	1,702
Provision for/(Benefit from) credit and insurance losses	438	46	(298)
Pension and Other Postretirement Employee Benefits (OPEB) expense/(income)	3,052	(378)	(4,865)
Equity method investment dividends received in excess of (earnings)/losses and impairments	(33)	3,324	116
Foreign currency adjustments	(234)	(27)	532
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	205	7,518	(9,159)
(Gains) Losses On Changes In Investments In Affiliates	(9)	147	(368)
Stock compensation (Note 6)	460	336	305
Provision for deferred income taxes	(1,649)	(1,910)	(563)
Increase (Decrease) in Finance Receivables	(4,827)	(10,560)	7,656
Decrease/(Increase) in accounts receivable and other assets	(2,620)	(1,183)	(1,141)
Decrease/(Increase) in inventory	(1,219)	(2,576)	(1,778)
Increase/(Decrease) in accounts payable and accrued and other liabilities	9,829	7,268	(36)
Other Operating Activities, Cash Flow Statement	673	386	(186)
Net cash provided by/(used in) operating activities	14,918	6,853	15,787
Cash flows from investing activities
Capital spending	(8,236)	(6,866)	(6,227)
Acquisitions of finance receivables and operating leases	(54,505)	(45,533)	(48,379)
Collections of finance receivables and operating leases	44,561	46,276	52,094
Proceeds from sale of business	0	449	145
Payments to Acquire Marketable Securities	(8,590)	(17,458)	(27,491)
Sales and maturities of marketable securities and other investments	12,700	19,117	33,229
Settlements of derivatives	(138)	94	(272)
Capital contributions to equity method investments	(2,733)	(738)	(57)
Other	(687)	312	(297)
Net Cash Provided by (Used in) Investing Activities	(17,628)	(4,347)	2,745
Cash flows from financing activities
Cash payments for dividends and dividend equivalents	(4,995)	(2,009)	(403)
Purchases of common stock	(335)	(484)	0
Net changes in short-term debt	(1,539)	5,460	3,273
Proceeds from Issuance of Long-Term Debt	51,659	45,470	27,901
Repayments of Long-Term Debt	(41,965)	(45,655)	(54,164)
Other	(241)	(271)	(105)
Net Cash Provided by (Used in) Financing Activities	2,584	2,511	(23,498)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(104)	(414)	(232)
Cash, cash equivalents, and restricted cash at beginning of period (Note 9)	25,340	20,737	25,935
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(230)	4,603	(5,198)
Cash, cash equivalents, and restricted cash at end of period (Note 9)	$ 25,110	$ 25,340	$ 20,737